Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Sarnelli

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Journal of Neurogastroenterology and Motility|October 10, 2023
Modern Achalasia: Diagnosis, Classification, and TreatmentMarcella Pesce, Marta Pagliaro, Giovanni Sarnelli, et al.
Internal and Emergency Medicine|September 21, 2025
GLP-1 and GIP agonists in diabetes and obesity and the rise of dyspepsiaMaria Masulli, Jan Tack, Giuseppe Esposito, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2018
Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndromeEugenia Bruzzese, Marcella Pesce, Giovanni Sarnelli, et al.
Biomedicines|January 28, 2026
Palmitoylethanolamide for Nickel Allergy: Plausible, Untested, and Worth ConsideringIrene Palenca, Silvia Basili Franzin, Giovanni Sarnelli, et al.
The American Journal of Gastroenterology|May 10, 2003
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsiaGiovanni Sarnelli, Philip Caenepeel, Benny Geypens, et al.
World Journal of Gastrointestinal Pathophysiology|November 19, 2013
Genetic contribution to motility disorders of the upper gastrointestinal tractGiovanni Sarnelli, Alessandra D'Alessandro, Marcella Pesce, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2025
Targeting metabolic syndrome with ALIAmides: A novel multi-mechanistic approachIrene Palenca, Maria Masulli, Sara Rurgo, et al.
Pharmacological Reports : PR|February 23, 2026
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging usesIrene Palenca, Silvia Basili Franzin, Marcella Pesce, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 24, 2004
Inhibitory effects of galanin on evoked [Ca2+]i responses in cultured myenteric neuronsGiovanni Sarnelli, Pieter Vanden Berghe, Petra Raeymaekers, et al.
Minerva Gastroenterologica E Dietologica|December 16, 2016
Rationale and evidences for treatment of symptomatic uncomplicated diverticular diseaseRosario Cuomo, Martina Cargiolli, Paolo Andreozzi, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Journal of Neurogastroenterology and Motility|October 10, 2023
Modern Achalasia: Diagnosis, Classification, and TreatmentMarcella Pesce, Marta Pagliaro, Giovanni Sarnelli, et al.
Internal and Emergency Medicine|September 21, 2025
GLP-1 and GIP agonists in diabetes and obesity and the rise of dyspepsiaMaria Masulli, Jan Tack, Giuseppe Esposito, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2018
Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndromeEugenia Bruzzese, Marcella Pesce, Giovanni Sarnelli, et al.
Biomedicines|January 28, 2026
Palmitoylethanolamide for Nickel Allergy: Plausible, Untested, and Worth ConsideringIrene Palenca, Silvia Basili Franzin, Giovanni Sarnelli, et al.
The American Journal of Gastroenterology|May 10, 2003
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsiaGiovanni Sarnelli, Philip Caenepeel, Benny Geypens, et al.
World Journal of Gastrointestinal Pathophysiology|November 19, 2013
Genetic contribution to motility disorders of the upper gastrointestinal tractGiovanni Sarnelli, Alessandra D'Alessandro, Marcella Pesce, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2025
Targeting metabolic syndrome with ALIAmides: A novel multi-mechanistic approachIrene Palenca, Maria Masulli, Sara Rurgo, et al.
Pharmacological Reports : PR|February 23, 2026
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging usesIrene Palenca, Silvia Basili Franzin, Marcella Pesce, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 24, 2004
Inhibitory effects of galanin on evoked [Ca2+]i responses in cultured myenteric neuronsGiovanni Sarnelli, Pieter Vanden Berghe, Petra Raeymaekers, et al.
Minerva Gastroenterologica E Dietologica|December 16, 2016
Rationale and evidences for treatment of symptomatic uncomplicated diverticular diseaseRosario Cuomo, Martina Cargiolli, Paolo Andreozzi, et al.
Pageof 15